| abstract |
The present invention relates to novel 4- (heterocyclyl) alkyl-N- (arylsulfonyl) indole compounds of structural formula (I), derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salts thereof and pharmaceuticals containing them. Pertains to a chemically acceptable composition. The invention also relates to a process for the preparation of said novel compounds, derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salts thereof and pharmaceutically acceptable compositions containing them. These compounds are useful in the treatment of a variety of disorders associated with 5-HT 6 receptor function. Specifically, the compounds of the present invention are also useful in the treatment of various CNS disorders, blood disorders, eating disorders, painful illnesses, respiratory diseases, genital-urinary disorders, cardiovascular diseases and cancer. Useful. |